At this panel from Ending Age-Related Diseases 2020, Javier Noris of Lifespan.io talks with Patrick Burgermeister of Kizoo Ventures, Reason of Repair Biotechnologies, Sergio Ruiz of Methuselah Labs, and Ronjon Nag of Institute R42 about the valley of death in biotech investment. Early-stage research is funded by universities and governments, and companies are funded by investors, but it is difficult for researchers to bring their findings to the level at which investors would be interested, and being unable to cross this valley of death is a significant hindrance for the development of rejuvenation biotechnology. Being able to reliably overcome this would be a major benefit for the development of therapies that directly target the root causes of aging.
HELP SPREAD THE WORD
Please connect with us on social media, like and share our content, and help us build grass-roots support for healthy life extension:
A study published in the Nature journal Aging and Mechanisms of Disease has shown that supplementation with nicotinamide riboside (NR) substantially improves the immune systems of older mice due to its effects […]
We continue discussing cellular reprogramming on Science to Save the World, our general science show. In Part 2, we discuss a mouse experiment that used the OSKM reprogramming factors. Script Could we “reprogram” old cells to […]
On this hopeful episode of Lifespan News, Ryan O’Shea discusses the odds of any individual living to 130, even in the absence of rejuvenation biotechnology. Script Could humans live forever? It’s theoretically possible, according to a new […]
Dylan Livingston is the founder and president of A4LI – the Alliance for Longevity Initiatives. This newly created organization aims to fill an important niche as a non-profit that would educate American politicians on life extension […]
A new study in Nature Genetics has further illuminated the genetic regulation of telomere length and what implications it may have for various diseases and longevity. Telomeres and aging in […]
You have 3 free articles remaining this week. You can register for free to continue enjoying the best in rejuvenation biotechnology news. Already registered? Login here.
Write a comment: